Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant human monoclonal antibody against human complement component C5a |
---|---|
Date Designated: | 10/06/2016 |
Orphan Designation: | Treatment of acute graft versus host disease |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 09/21/2017 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Alexion Pharmaceuticals, Inc. 100 College Street New Haven, Connecticut 06510 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-